Long-term follow-up of cardiovascular disease risk factors in children after an obesity intervention

American Journal of Clinical Nutrition

Volumn 84, Issue 3, 2006, Pages 490-496

  Reinehr, Thomas ^a   De Sousa, Gideon ^a   Toschke, André Michael ^b   Andler, Werner ^a  

^a UNIVERSITY OF WITTEN HERDECKE   (Germany)

^b UNIVERSITY OF MUNICH   (Germany)

Author keywords

Blood pressure; Children; Follow up obesity; Glucose; HDL cholesterol; Insulin; LDL cholesterol; Lipids; Outpatient intervention program; Triacylglycerol; Weight loss

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADOLESCENT; ARTICLE; BLOOD PRESSURE; BODY MASS; BODY WEIGHT; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHILD; CONTROLLED STUDY; EXERCISE; FOLLOW UP; HOMEOSTASIS; HUMAN; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; NUTRITION EDUCATION; OBESITY; RISK ASSESSMENT; RISK FACTOR; BEHAVIOR THERAPY; BLOOD; CASE CONTROL STUDY; CHILD NUTRITION; DIET THERAPY; EDUCATION; FEMALE; LONGITUDINAL STUDY; MALE; PHYSIOLOGY; WEIGHT REDUCTION;

ADOLESCENT; BEHAVIOR THERAPY; BLOOD PRESSURE; BODY MASS INDEX; CARDIOVASCULAR DISEASES; CASE-CONTROL STUDIES; CHILD; CHILD NUTRITION PHYSIOLOGY; EXERCISE; FEMALE; FOLLOW-UP STUDIES; HUMANS; INSULIN RESISTANCE; LIPIDS; LONGITUDINAL STUDIES; MALE; OBESITY; RISK FACTORS; WEIGHT LOSS;

EID: 33750112880     PISSN: 00029165     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajcn/84.3.490     Document Type: Article

References (33)

1. Ebbeling CA, Pawlak DB, Ludwig DS. Childhood obesity: public-health crisis, commonsense cure. Lancet 2002;360:473-82.
2. Jiang X, Srinivasan SR, Webber LS, et al. Association of fasting insulin level with serum lipid and lipoprotein levels in children, adolescents, and young adults: the Bogalusa Heart Study. Arch Intern Med 1995;23:190-6.
3. Facchini FS, Hua N, Abbasi F, Reaven GM. Insulin resistance as a predictor of age-related diseases. J Clin Endocrinol Metab 2001;86:3574-8.
4. Reinehr T, Kiess W, de Sousa G, Stoffel- Wagner B, Wunsch R. Intima-media thickness in childhood obesity: relations to inflammatory marker, glucose metabolism, and blood pressure. Metabolism 2006;55:113-8.
5. Sung RYT, Yu CW, Chang SKY, et al. Effects of dietary intervention and strength training on blood lipid levels in obese children. Arch Dis Child 2002;86:407-10.
6. Knip M, Nuutinien O. Long-term effects of weight reduction on serum lipids and plasma insulin in obese children. Am J Clin Nutr 1993;57:490-3.
7. Wabitsch M, Hauner H, Heinze E, et al. Body-fat distribution and changes in atherogenic risk-factor profile in obese adolescent girls during weight loss. Am J Clin Nutr 1994;60:54-60.
8. Reinehr T, Kiess W, Kapellen T, Andler W. Insulin sensitivity among obese children and adolescents, according to degree of weight loss. Pediatrics 2004;114:1569-73.
9. Reinehr T, Andler W. Changes in the atherogenic risk-factor profile according to degree of weight loss. Arch Dis Child 2004;89:419-22.
10. Epstein LH, Kuller LH, Wing RR, et al. The effect of weight control on lipid changes in obese children. Am J Dis Child 1989;143:454-7.
11. Reinehr T, Dobe M, Kersting M: Therapie der Adipositas im Kindesund Jugendalter: Die Adipositasschulung Obeldicks. (Treatment of obesity in childhood and adolescence: the Obeldicks obesity intervention program.) Göttingen, Germany: Hogreve Verlag, 2003 (in German).
12. Reinehr T, Brylak K, Alexy U, et al. Predictors to success in outpatient training in obese children and adolescents. Int J Obes Relat Metab Disord 2003;27:1087-92.
13. Reinehr T, Kersting M, Alexy U, et al. Long-term follow-up of overweight children: after training, after a single consultation session and without treatment. J Pediatr Gastroenterol Nutr 2003;37:72-4.
14. Alexy U, Sichert-Hellert W, Kersting M, Manz F. The foods most consumed by German children and adolescents: results of the DONALD Study. Ann Nutr Metab 2001;45:128-34.
15. Kersting M, Sichert-Hellert W, Lausen B, Alexy U, Manz F, Schöch G. Energy intake of 1 to 18 year old German children and adolescents. Z Ernährungswiss 1998;37:47-55.
16. Epstein LH, Roemmich JN, Raynor HA. Behavioral therapy in the treatment of pediatric obesity. Pediatr Clin North Am 2001;48:981-93.
17. Reinehr T, Kersting M, Wollenhaupt A, et al. Evaluation of the training program "Obeldicks" for obese children and adolescents. Klin Padiatr 2005;217:1-8 (in German).
18. Kromeyer-Hauschild K, Wabitsch M, Geller F, et al. Percentiles of body mass index in children and adolescents evaluated from different regional German studies. Monatsschr Kinderheilkd 2001;149:807-18 (in German).
19. Cole TJ. The LMS method for constructing normalized growth standards. Eur J Clin Nutr 1990;44:45-60.
20. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985;28:412-9.
21. Rosner B, Prineas RJ, Loggie JM, et al. Blood pressure normograms for children and adolescents by height, sex, and age, in the United States. J Pediatr 1993;123:871-86.
22. Weerahandi S. Exact methods in MANOVA and mixed models. Oxford, United Kingdom: Wiley Interscience, 2004.
23. Isomaa B, Almgren P, Tuomi T, et al. Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care 2001;24:683-9.
24. De Jongh S, Ose L, Szamosi T et al. Efficacy and safety of statin therapy in children with familial hypercholesterolemia: a randomized, doubleblind, placebo-controlled trial with simvastatin. Circulation 2002;106:2231-7.
25. Dirisamer A, Hachemian N, Bucek RA, et al. The effect of low-dose simvastatin in children with familial hypercholesterolaemia: a 1-year observation. Eur J Pediatr 2003;162:421-5.
26. Hanson L. Hedner T. Lindholm L, et al. The Captopril Prevention Project (CAPPP) in hypertension - baseline data and current status. Blood Press 1997;6:365-7.
27. Wang JG, Staessen JA. Benefits of antihypertensive pharmacologic therapy and blood pressure reduction in outcome trials. J Clin Hypertens 2003;5:66-75.
28. Kraus WE, Houmard J, Duscha B, et al. Effects of the amount and intensity of exercise on plasma lipoproteins. N Engl J Med 2002;347:1483-92.
29. Skov AR, Toubro S, Ronn B et al. Randomized trial on protein vs carbohydrate in ad libitum fat reduced diet for the treatment of obesity. Int J Obes Relat Metob Disord 1999;23:528-536.
30. Uusitupa MIJ, Laakso M, Sarlund H, et al. Effects of very-low-caloric diet on metabolic control and cardiovascular risk factors in the treatment of obese non-insulin-dependent diabetics. Am J Clin Nutr 1990;51:768-73.
31. Rössner S, Björvell H. Early and late effects of weight loss on lipoprotein metabolism in severe obesity. Atherosclerosis 1987;64:125-30.
32. Maffeis C, Pietrobelli A, Grezzani A, Provera S, Tato L. Waist circumference and cardiovascular risk factors in prepubertal children. Obes Res 2001;9:179-87.
33. Wallace TM, Matthews DR. The assessment of insulin resistance in man. Diabet Med 2002;19:527-34.